TY  - JOUR
A1  - Van de Kerkhof, Noortje W. A.
A1  - Feenstra, Ilse
A1  - van der Heijden, Frank M. M. A.
A1  - de Leeuw, Nicole
A1  - Pfundt, Rolph
A1  - Stöber, Gerald
A1  - Egger, Jos I. M.
A1  - Verhoeven, Willem M. A.
T1  - Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice?
JF  - Neuropsychiatric Disease and Treatment
N2  - With the introduction of new genetic techniques such as genome-wide array comparative genomic hybridization, studies on the putative genetic etiology of schizophrenia have focused on the detection of copy number variants (CNVs), ie, microdeletions and/or microduplications, that are estimated to be present in up to 3% of patients with schizophrenia. In this study, out of a sample of 100 patients with psychotic disorders, 80 were investigated by array for the presence of CNVs. The assessment of the severity of psychiatric symptoms was performed using standardized instruments and ICD-10 was applied for diagnostic classification. In three patients, a submicroscopic CNV was demonstrated, one with a loss in 1q21.1 and two with a gain in 1p13.3 and 7q11.2, respectively. The association between these or other CNVs and schizophrenia or schizophrenia-like psychoses and their clinical implications still remain equivocal. While the CNV affected genes may enhance the vulnerability for psychiatric disorders via effects on neuronal architecture, these insights have not resulted in major changes in clinical practice as yet. Therefore, genome-wide array analysis should presently be restricted to those patients in whom psychotic symptoms are paired with other signs, particularly dysmorphisms and intellectual impairment.
KW  - microarrays
KW  - spectrum disorders
KW  - schizophrenia
KW  - gene
KW  - psychopathology
KW  - polymorphisms
KW  - microdeletion
KW  - perspectives
KW  - association
KW  - environment
KW  - copy number variants
KW  - 1q21
KW  - 7q11.2
KW  - 1p13.3
Y1  - 2012
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-134769
VL  - 8
ER  - 
TY  - JOUR
A1  - Klotz, Barbara
A1  - Mentrup, Birgit
A1  - Regensburger, Martina
A1  - Zeck, Sabine
A1  - Schneidereit, Jutta
A1  - Schupp, Nicole
A1  - Linden, Christian
A1  - Merz, Cornelia
A1  - Ebert, Regina
A1  - Jakob, Franz
T1  - 1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
JF  - PLoS ONE
N2  - 1,25-dihydroxyvitamin D3 (1,25D3) was reported to induce premature organismal aging in fibroblast growth factor-23 (Fgf23) and klotho deficient mice, which is of main interest as 1,25D3 supplementation of its precursor cholecalciferol is used in basic osteoporosis treatment. We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC). Effects of 100 nM 1,25D3 on hMSC were analyzed by cell proliferation and apoptosis assay, beta-galactosidase staining, VDR and surface marker immunocytochemistry, RT-PCR of 1,25D3-responsive, quiescence-and replicative senescence-associated genes. 1,25D3 treatment significantly inhibited hMSC proliferation and apoptosis after 72 h and delayed the development of replicative senescence in long-term cultures according to beta-galactosidase staining and P16 expression. Cell morphology changed from a fibroblast like appearance to broad and rounded shapes. Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways. In conclusion, 1,25D3 delays replicative senescence in primary hMSC while the pro-aging effects seen in mouse models might mainly be due to elevated systemic phosphate levels, which propagate organismal aging.
KW  - perspectives
KW  - bone marrow
KW  - mutant mice
KW  - oxidative stress
KW  - transcription factors
KW  - vitamin-D-receptor
KW  - differentiation
KW  - tissue
KW  - 2',7'-dichlorofluorescin
KW  - homeostasis
Y1  - 2012
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-133392
VL  - 7
IS  - 1
ER  -